|
DE2965655D1
(en)
|
1978-06-28 |
1983-07-21 |
Beecham Group Plc |
Secondary amines, their preparation, pharmaceutical compositions containing them and their use
|
|
US4338333A
(en)
|
1979-06-16 |
1982-07-06 |
Beecham Group Limited |
Ethanamine derivatives their preparation and use in pharmaceutical compositions
|
|
ATE1899T1
(de)
|
1979-06-16 |
1982-12-15 |
Beecham Group Plc |
Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
|
|
PT82120B
(en)
|
1985-03-01 |
1988-06-16 |
Beecham Group Plc |
Process for preparing veterinary formulations containing ethanolamine derivatives
|
|
GB8528633D0
(en)
|
1985-11-21 |
1985-12-24 |
Beecham Group Plc |
Compounds
|
|
IT1204416B
(it)
|
1986-06-27 |
1989-03-01 |
Midy Spa |
Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
|
|
GB8801306D0
(en)
|
1988-01-21 |
1988-02-17 |
Ici Plc |
Chemical compounds
|
|
ATE144139T1
(de)
|
1989-06-13 |
1996-11-15 |
Sanofi Sa |
Verwendung von phenylethanolaminen zur herstellung von medikamenten gegen augenleiden
|
|
GB8925032D0
(en)
|
1989-11-06 |
1989-12-28 |
Ici Plc |
Chemical compounds
|
|
US5061727A
(en)
|
1990-05-04 |
1991-10-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
|
ATE185564T1
(de)
|
1992-08-31 |
1999-10-15 |
Sankyo Co |
Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
|
|
US5578638A
(en)
|
1993-11-05 |
1996-11-26 |
American Cyanamid Company |
Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
NO303782B1
(no)
|
1994-03-23 |
1998-08-31 |
Sankyo Co |
Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
US5561142A
(en)
|
1994-04-26 |
1996-10-01 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
JP3100165B2
(ja)
|
1994-11-29 |
2000-10-16 |
大日本製薬株式会社 |
インドール誘導体
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
ES2158996T3
(es)
|
1995-09-21 |
2001-09-16 |
Lilly Co Eli |
Agonistas beta3 adrenergicos selectivos.
|
|
ZA967892B
(en)
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
|
CZ126598A3
(cs)
|
1995-10-26 |
1998-09-16 |
Mitsubishi-Tokyo Pharmaceuticals, Inc. |
Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
|
|
WO1997025311A1
(en)
|
1996-01-10 |
1997-07-17 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Novel tricyclic compounds and drug compositions containing the same
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
EP0801060A1
(en)
|
1996-04-09 |
1997-10-15 |
Pfizer Inc. |
Heterocyclic Beta-3 Adrenergenic Agonists
|
|
JP2000511903A
(ja)
|
1996-06-07 |
2000-09-12 |
メルク エンド カンパニー インコーポレーテッド |
糖尿病および肥満の治療のための選択性β▲下3▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド
|
|
EP0827746B1
(en)
|
1996-09-05 |
2002-04-03 |
Eli Lilly And Company |
Carbazole analogues as selective beta3 adrenergic agonists
|
|
IL131130A0
(en)
|
1997-01-28 |
2001-01-28 |
Merck & Co Inc |
Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
|
|
AU735249B2
(en)
|
1997-07-03 |
2001-07-05 |
Asahi Kasei Kabushiki Kaisha |
Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
|
|
HUP0301329A2
(hu)
|
2000-07-13 |
2003-08-28 |
Eli Lilly And Co. |
Béta3 Adrenergiás agonisták, valamint ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás e vegyületek előállítására
|
|
US6537994B2
(en)
|
2000-07-17 |
2003-03-25 |
Wyeth |
Heterocyclic β3 adrenergic receptor agonists
|
|
US20040242485A1
(en)
|
2003-05-30 |
2004-12-02 |
Takashi Kadowaki |
Compositions and methods for the amelioration of leptin resistance
|
|
CN103068400A
(zh)
|
2010-06-25 |
2013-04-24 |
阿斯顿大学 |
具有脂类动员性质的糖蛋白及其治疗用途
|
|
CN102764438A
(zh)
|
2012-01-30 |
2012-11-07 |
林曙光 |
β3肾上腺素受体激动剂的新用途
|